Small Lymphocytic Leukemia (SLL)
4 clinical trials · Condition
◉ Watch Small Lymphocytic Leukemia (SLL)
| Record | Firm | Date |
|---|---|---|
| Duvelisib for Ibrutinib-Resistant Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (NCT04209621) | National Heart, Lung, and Blood Institute (NHLBI) | 2020-07-31 |
| A Study of the Safety and Efficacy of Venetoclax in Japanese Participants With Relapsed and Refractory Chronic Lymphocytic Leukemia (Including Small Lymphocytic Leukemia) (NCT04198415) | AbbVie | 2020-02-03 |
| Study of Zanubrutinib, Obinutuzumab, and Venetoclax in Patients With Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL) (NCT03824483) | Memorial Sloan Kettering Cancer Center | 2019-02-22 |
Track Small Lymphocytic Leukemia (SLL) automatically
Every clearance here is in the API, with alerts when new ones post.